NASDAQ: XOMA
Xoma Royalty Corp Stock

$31.37-0.22 (-0.7%)
Updated Aug 15, 2025
XOMA Price
$31.37
Fair Value Price
-$28.81
Market Cap
$379.19M
52 Week Low
$18.35
52 Week High
$35.00
P/E
-20.64x
P/B
5.23x
P/S
3.1x
PEG
N/A
Dividend Yield
N/A
Revenue
$44.95M
Earnings
-$12.39M
Gross Margin
100%
Operating Margin
-9.92%
Profit Margin
-27.6%
Debt to Equity
1.81
Operating Cash Flow
-$3M
Beta
0.86
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

XOMA Overview

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine XOMA's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
XOMA
Ranked
#30 of 482

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important XOMA news, forecast changes, insider trades & much more!

XOMA News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XOMA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XOMA ($31.37) is overvalued by 208.89% relative to our estimate of its Fair Value price of -$28.81 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
XOMA ($31.37) is not significantly undervalued (208.89%) relative to our estimate of its Fair Value price of -$28.81 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
XOMA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more XOMA due diligence checks available for Premium users.

Valuation

XOMA fair value

Fair Value of XOMA stock based on Discounted Cash Flow (DCF)

Price
$31.37
Fair Value
-$28.81
Undervalued by
208.89%
XOMA ($31.37) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XOMA ($31.37) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XOMA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

XOMA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-20.64x
Industry
-120.52x
Market
35.99x

XOMA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.23x
Industry
4.5x
XOMA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XOMA's financial health

Profit margin

Revenue
$13.1M
Net Income
$9.2M
Profit Margin
70%
XOMA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
XOMA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$223.5M
Liabilities
$131.0M
Debt to equity
1.81
XOMA's short-term assets ($104.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XOMA's long-term liabilities ($109.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XOMA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XOMA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$6.5M
Investing
-$20.0M
Financing
-$3.0M
XOMA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

XOMA vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
XOMAB$379.19M-0.70%-20.64x5.23x
OLMAF$378.18M+4.75%-2.95x1.10x
NBTX$375.15M-3.54%-4.94x-5.14x
YMAB$385.82M+0.12%-13.31x4.31x
ATXSD$386.58M+1.33%-3.41x1.48x

Xoma Royalty Stock FAQ

What is Xoma Royalty's quote symbol?

(NASDAQ: XOMA) Xoma Royalty trades on the NASDAQ under the ticker symbol XOMA. Xoma Royalty stock quotes can also be displayed as NASDAQ: XOMA.

If you're new to stock investing, here's how to buy Xoma Royalty stock.

What is the 52 week high and low for Xoma Royalty (NASDAQ: XOMA)?

(NASDAQ: XOMA) Xoma Royalty's 52-week high was $35.00, and its 52-week low was $18.35. It is currently -10.37% from its 52-week high and 70.94% from its 52-week low.

How much is Xoma Royalty stock worth today?

(NASDAQ: XOMA) Xoma Royalty currently has 12,087,719 outstanding shares. With Xoma Royalty stock trading at $31.37 per share, the total value of Xoma Royalty stock (market capitalization) is $379.19M.

Xoma Royalty stock was originally listed at a price of $1,668.90 in Dec 31, 1997. If you had invested in Xoma Royalty stock at $1,668.90, your return over the last 27 years would have been -98.12%, for an annualized return of -13.69% (not including any dividends or dividend reinvestments).

How much is Xoma Royalty's stock price per share?

(NASDAQ: XOMA) Xoma Royalty stock price per share is $31.37 today (as of Aug 15, 2025).

What is Xoma Royalty's Market Cap?

(NASDAQ: XOMA) Xoma Royalty's market cap is $379.19M, as of Aug 17, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Xoma Royalty's market cap is calculated by multiplying XOMA's current stock price of $31.37 by XOMA's total outstanding shares of 12,087,719.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.